Author

Jiang Wang

Ministry of Agriculture and Rural Affairs

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:deep learning· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Abigail G. Branch· 1 shared Bei‐Bei ChuiD· 1 shared Elliott B. BurdetteiD· 1 shared Eugene DouglassiD· 1 shared Frédéric HollandeiD· 1 shared Gregory Lawrence BeattyiD· 1 shared Jayati L. ChakrabartiiD· 1 shared Jia-Jia PaniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abigail G. Branch

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The targeted cytosolic degradation of class I histone deacetylases is essential for efficient alphaherpesvirus replication

Sheng‐Li Ming, Meng-Hua Du, Jia-Ming Yang, Ya-di Guo, Jia-Jia Pan, Weifei Lu, Jiang Wang, Lei Zeng, Bei‐Bei Chu

This study shows alphaherpesviruses degrade class I HDACs to activate DDR and enhance replication, identifying potential therapeutic targets.

bioRxiv · Jun 8, 2026Cell Biology

Spatial Biology and Organoid Technologies Reveal a Potential Therapy-Resistant Cancer Stem Cell Population in Pancreatic Ductal Adenocarcinoma

Pritha Adhikary, Jayati L. Chakrabarti, Saptarshi Mallick, Xi Sun, Ugonna Ezuma-Igwe, Abigail G. Branch, Jiang Wang, Nicolas Braissand, Megan P. Corbett, Sangmin Kim, Rohan Kanakamedala, Willian C. Bastian, Eugene Douglass, Meenu Priya Resmi, Payton D. Stevens, , Yana L. Zavros

The paper uses spatial imaging and organoid models to identify therapy-resistant CD44v9+ cancer stem cells in PDAC and show that cabozantinib may enhance immunotherapy by altering the tumor microenvironment.

bioRxiv · May 22, 2025 · PreprintCancer Biology